Author profile
Alejandra is a biomedical engineer with a PhD in Biological Sciences and over five years of experience in product development, specialising in drug delivery and diagnostic devices. She has supported projects from early concept through to regulatory submission and market launch. Passionate about strategy and innovation, Alejandra enjoys advising clients and working at the forefront of deep tech.
The new era of innovation will be defined by those who harness deep tech to put people at the centre. This report helps leaders across consumer, healthcare and industry understand shifting markets, uncover new opportunities and lead the next wave of innovation.
Alejandra Sanchez and Ben Wicks explore why primary care needs timely, pragmatic insight, not lab-grade certainty, to enable better antibiotic decisions and stewardship.
Dr Alejandra Sanchez and Charlie Dean consider the evolution of drug delivery technologies and how cell and gene therapies are showing promise as a new class of medicine to correct disease at its source.